Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

New York Academy of Sciences: T Cells at the Interface of Immune-CNS Cross-Talk
Randomized controlled trial of interferon-beta-1a in secondary progressive MS: MRI results.
Cladribine interferes with IL-1β synaptic effects in experimental multiple sclerosis.
Therapeutic vaccine for acute and chronic motor neuron diseases: implications for amyotrophic lateral sclerosis.
Impact of cladribine on soluble adhesion molecules in multiple sclerosis.
Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration.
Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine.
The relation between inflammation and neurodegeneration in multiple sclerosis brains.
Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis.
Natalizumab treatment decreases serum IgM and IgG levels in multiple sclerosis patients.
Focal vibration in neurorehabilitation.
Genzyme’s LEMTRADA™ (alemtuzumab) application for MS accepted for review by the FDA
Ustekinumab success in refractory Crohn’s disease
Neuromyelitis optica and pregnancy during therapeutic B cell depletion: infant exposure to anti-AQP4 antibody and prevention of rebound relapses with low-dose rituximab postpartum.
Prevalence of neurological disorders in Al Quseir, Egypt: methodological aspects.
Clinical relevance of serum natalizumab concentration and anti-natalizumab antibodies in multiple sclerosis.
Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study.
A G protein-coupled receptor is essential for Schwann cells to initiate myelination.
Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis.
Patient Satisfaction with the New Interferon Beta-1b Autoinjector (BETACONNECT™).
Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy.
Rituximab in relapsing and progressive forms of multiple sclerosis: a systematic review.
Santhera's Phase III program with Catena®/Raxone® in Duchenne muscular dystrophy on track to deliver pivotal data early in 2Q 2014
American Academy of Neurology Annual Meeting
Glatiramer acetate ameliorates inflammatory bowel disease in mice through the induction of Qa-1-restricted CD8⁺ regulatory cells.

Pages